Immunoglobulin A Nephropathy

Advertisement

cGxPJobs Banner

Alexion’s Ultomiris Gets FDA Priority Review for IgAN

BOSTON, US | June 15, 2026 Alexion, AstraZeneca Rare Disease announced that the U.S. Food and Drug Administration (FDA)...

By cGxPwire Editor
June 20, 2026

Read More

Advertisement

cGxPJobs

Directory